source
- Verge Labs launches AI tool to boost patient enrollment and trial efficiency; Moderna appoints new chief commercial officerVerge Labs announced a new artificial‑intelligence model designed to identify patients most likely to respond to a therapy, aiming to reduce dropout rates and increase the statistical power of clin…
- Verge Labs launches AI tool to improve neurology trial patient selection after ALS setbackVerge Labs, formerly known as Verge Genomics, announced a new artificial intelligence model designed to address patient stratification challenges in neurology clinical trials. The company says the…